MNDs, exemplified by ALS, affect an estimated 5 per 100,000 individuals [58], with the most common genetic etiology, a hexanucleotide repeat expansion in C9orf72, accounting for 10% of patients with clinical ALS that can also be associated with FTD. Here, C9orf72 is linked to frontotemporal dementia.